Form 4: DENTSPLY SIRONA Executive Sells Shares

DENTSPLY SIRONA Inc. reports a transaction where President, CEO & Member of BOD Daniel T. Scavilla sold 4,095 shares of common stock.

Summary

• Daniel T. Scavilla, President, CEO & Member of the Board of Directors of DENTSPLY SIRONA Inc., engaged in a stock transaction on May 22, 2026.
• The transaction involved the disposal of 4,095 shares of common stock.
• The sale price was $10.21 per share.
• Following this transaction, Mr. Scavilla beneficially owns 157,754 shares of common stock directly.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a slightly negative sentiment due to a key executive selling shares, although the reason for withholding to cover taxes is a mitigating factor.

Negatives

• A significant number of shares were disposed of by a key executive.

Risks

• Potential negative signal to the market from a senior executive selling shares.

Future Outlook

No forward-looking statements or guidance were provided in this filing.

Industry Context

StockSavvy.ai notes that Form 4 filings, which report changes in beneficial ownership by insiders, are closely watched by investors. Significant sales by top executives can sometimes be interpreted as a lack of confidence in the company's near-term prospects, although tax-related withholding is also a common reason for such transactions.

Stakeholder Impact

• Shareholders may view the sale by the CEO as a negative signal, potentially impacting stock price in the short term.

Key Dates

Recommendation

The filing reports a stock sale by the CEO, which can be a negative indicator. However, the sale was for tax withholding related to RSUs, a common and often non-indicative transaction. Without further context on the company's performance or future outlook, a 'hold' recommendation is prudent, advising investors to monitor for additional information.

Keywords

DENTSPLY SIRONA, XRAY, Form 4, insider trading, stock sale, Daniel T. Scavilla, executive compensation